Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;43(1):6-12.
doi: 10.1111/jvp.12820. Epub 2019 Oct 25.

Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses

Jocelyn Habershon-Butcher  1 , Charlotte Cutler  2 , Marjaana Viljanto  2 , Pamela R Hincks  2 , Simon Biddle  2 , Stuart W Paine  3
Affiliations

Re-evaluation of the pharmacokinetics of xylazine administered to Thoroughbred horses

Jocelyn Habershon-Butcher et al. J Vet Pharmacol Ther. 2020 Jan.

Abstract

Xylazine is widely used worldwide as a short-acting sedative in general equine and racing practice. In the UK, although it has a legitimate use during training, equine anti-doping rules state it is a prohibited substance on race day. The aim of the study was to produce a detection time (DT) to better inform European veterinary surgeons so that xylazine can be used appropriately under regulatory rules. Previous publications have various limitations pertaining to analysis method, particularly for plasma and limited length of time of sample collection. In this study, pharmacokinetic data were produced for xylazine and 4-OH-xylazine in equine urine and plasma following a single intravenous xylazine dose of 0.4 mg/kg to six Thoroughbred horses. Pharmacokinetic parameters were generated from a 3-compartmental model with clearance = 15.8 ± 4.88 ml min-1 kg-1 , Vss = 1.44 ± 0.38 L/kg, terminal half-life = 29.8 ± 12.7 hr and a DT determined at 71 hr for the administration of xylazine (Chanazine® ) in plasma and urine. Urine screening should aim to detect the 4-OH-xylazine metabolite, which can act as an indicator for the xylazine plasma concentration. A DT of 72 hr has been agreed by the European Horserace Scientific Liaison Committee, to be implemented in June 2019.

Keywords: detection time; horse; pharmacokinetics; urine; xylazine.

PubMed Disclaimer

References

REFERENCES

    1. Association of Racing Commissioners International (2017). Current therapeutic medications schedule, version 4. April. [ONLINE]. Retrieved from https://arci.blob.core.windows.net/webdocs/2017_04_CTS_V4_0.pdf
    1. Barragry, T. (2006). Doping and drug detection times in horses: New data for therapeutic agents. Coninuing Education. Irish Veterinary Journal, 59, 394-398.
    1. British Horseracing Authority (2015). Equine Anti-Doping Manual (G), Schedule 1- Prohibited List. [ONLINE]. Retrieved from http://rules.britishhorseracing.com/Orders-and-rules&staticID=126988...
    1. Hannan, C., O'Connor, M., & Barragry, T. (2004). Controlling therapeutic substances - A European harmonized approach: 5. Pharmacokinetic studies on eltenac, butorphanol and xylazine in the horse. Proceedings of 15th ICRAV, Dubai, United Arab Emirates.
    1. Hubbell, J. A. E., Saville, W. J. A., & Bednarski, R. M. (2010). The use of sedatives, analgesic and anaesthetic drugs in the horse: An electronic survey of members of the American Association of Equine Practitioners (AAEP). Equine Veterinary Journal, 42, 487-493. https://doi.org/10.1111/j.2042-3306.2010.00104.x

Publication types